Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novavax reported $-312768000 in EBIT for its fiscal quarter ending in March of 2023.

Ebit Change
AstraZeneca AZN:LN USD 2.78B 943M
BioCryst Pharmaceuticals BCRX:US USD -28415000 17.9M
Geron GERN:US USD -40092000 1.86M
GlaxoSmithKline GSK:LN GBP 1.92B 483M
MannKind MNKD:US USD -5044000 4.27M
Merck & Co MRK:US USD 4.41B 1.14B
Minerva Neurosciences NERV:US USD -5348520 278.79K
Moderna Inc MRNA:US USD -366000000 1.95B
Novartis NVS:US USD 3.23B 123M
Novavax NVAX:US USD -312768000 68.89M
Peregrine Pharmaceuticals PPHM:US USD 2.72M 5.4M
Pfizer PFE:US USD 6.91B 1.1B
Sarepta Therapeutics SRPT:US USD -138088000 31.26M
TG Therapeutics TGTX:US USD -36992000 15.07M